All Stories

  1. Patients with Nonischemic Cardiomyopathy Requiring Cardiac Resynchronization Therapy Should Also Undergo Implantation of a Primary Prevention Defibrillator

    Article • Cardiac Electrophysiology Clinics, September 2015, Elsevier

    Professor Francisco Leyva

  2. National Institute for Health and Care Excellence 2014 guidance on cardiac implantable electronic devices: health economics reloaded

    Article • EP Europace, February 2015, European Society of Cardiology

    Professor Francisco Leyva

  3. Myocardial strain measurement with feature-tracking cardiovascular magnetic resonance: normal values

    Article • European Heart Journal - Cardiovascular Imaging, February 2015, European Society of Cardiology

    Professor Francisco Leyva

  4. Implementation and reimbursement of remote monitoring for cardiac implantable electronic devices in Europe: a survey from the health economics committee of the European Heart Rhythm Association

    Article • EP Europace, February 2015, European Society of Cardiology

    Professor Francisco Leyva

  5. Longitudinal ventricular dyssynchrony on exercise in patients with heart failure and preserved ejection fraction

    Article • European Heart Journal, August 2013, European Society of Cardiology

    Professor Francisco Leyva

  6. RESynchronisation in Patients with heart failure and a Normal QRS Duration (RESPOND)

    Article • January 2013, Springer Science + Business Media

    Professor Francisco Leyva

  7. A randomised study on use of impedance cardiography for optimisation of cardiac resynchronisation therapy

    Article • January 2013, Springer Science + Business Media

    Professor Francisco Leyva

  8. Cardiac resynchronization therapy

    Article • September 2012, Oxford University Press (OUP)

    Professor Francisco Leyva

  9. Is the Pre-Ejection Period Key to Predicting the Response to Cardiac Resynchronization Therapy?

    Article • Circulation Journal, January 2012, Japanese Circulation Society

    Professor Francisco Leyva

  10. 81 Dyssynchronous three plane motion and impaired left ventricular twist in patients with heart failure and normal ejection fraction

    Article • Heart, June 2011, BMJ

    Professor Francisco Leyva

  11. Cardioverter-defibrillators: a cost or an investment?

    Article • EP Europace, April 2011, European Society of Cardiology

    Professor Francisco Leyva

  12. Myocardial scarring following chemotherapy for multiple myeloma detected using late gadolinium hyperenhancement cardiovascular magnetic resonance

    Article • Journal of Cardiovascular Medicine, May 2010, Wolters Kluwer Health

    Professor Francisco Leyva

  13. The DSC score

    Article • Heart, March 2010, BMJ

    Professor Francisco Leyva

  14. What is treatment success in cardiac resynchronization therapy?

    Article • EP Europace, October 2009, European Society of Cardiology

    Professor Francisco Leyva

  15. Inclusion and exclusion criteria for CRT

    Article • Heart Rhythm, August 2009, Elsevier

    Professor Francisco Leyva

  16. Asystole and scarring of the interventricular septum in hypertrophic cardiomyopathy

    Article • Journal of Cardiovascular Medicine, April 2009, Wolters Kluwer Health

    Professor Francisco Leyva

  17. Cardiac Resynchronization Therapy in Patients with Mildly Impaired Left Ventricular Function

    Article • Pacing and Clinical Electrophysiology, March 2009, Wiley

    Professor Francisco Leyva

  18. Extensive venous thrombosis and cardiomyopathy demonstrated with cardiovascular magnetic resonance

    Article • Journal of Cardiovascular Medicine, October 2008, Wolters Kluwer Health

    Professor Francisco Leyva

  19. Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of atrio-ventricular junction ablation in patients with permanent atrial fibrillation

    Article • European Heart Journal, July 2008, European Society of Cardiology

    Professor Francisco Leyva

  20. New Insights Into the Progression of Aortic Stenosis: Implications for Secondary Prevention Response

    Article • Circulation, March 2001, Wolters Kluwer Health

    Professor Francisco Leyva

  21. C-Reactive Protein, Serum Amyloid A Protein, and Coronary Events

    Article • Circulation, October 1999, Wolters Kluwer Health

    Professor Francisco Leyva

  22. The Metabolic Syndrome

    Article • January 1999, Springer Science + Business Media

    Professor Francisco Leyva

  23. Uric acid in chronic heart failure: a marker of chronic inflammation

    Article • European Heart Journal, December 1998, European Society of Cardiology

    Professor Francisco Leyva

  24. Uric acid in chronic heart failure: A measure of the anaerobic threshold

    Article • Metabolism, September 1998, Elsevier

    Professor Francisco Leyva

  25. The glycolytic pathway to coronary heart disease: A hypothesis

    Article • Metabolism, June 1998, Elsevier

    Professor Francisco Leyva

  26. Hyperleptinemia as a Component of a Metabolic Syndrome of Cardiovascular Risk

    Article • Journal of the American College of Cardiology, February 1998, Elsevier

    Professor Francisco Leyva

  27. A Non-invasive Test of Vascular Function Using Radial Artery Occlusion and Plethysmography

    Article • Journal of the American College of Cardiology, February 1998, Elsevier

    Professor Francisco Leyva

  28. Specialist training and the EC.

    Article • BMJ, October 1992, BMJ

    Professor Francisco Leyva

  29. Health Economics

    Article • Wiley

    Professor Francisco Leyva